Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Non-small cell lung cancer

  • You have access
    Prognostic Factors in Early-stage NSCLC: Analysis of the Placebo Group in the MAGRIT Study
    BYOUNG CHUL CHO, TOMMASO DE PAS, HARALABOS KALOFONOS, QUN WANG, RODRYG RAMLAU, YING CHENG, FABIANA VITIELLO, TANEL LAISAAR, ERIC VALLIÈRES, BARTOSZ KUBISA, SERGEY ORLOV, KEUNCHIL PARK, CHANNA DEBRUYNE and JOHAN VANSTEENKISTE
    Anticancer Research March 2019, 39 (3) 1403-1409; DOI: https://doi.org/10.21873/anticanres.13255
  • You have access
    Post-treatment Glasgow Prognostic Score Predicts Efficacy in Advanced Non-small-cell Lung Cancer Treated With Anti-PD1
    NORIMITSU KASAHARA, NORIAKI SUNAGA, YUSUKE TSUKAGOSHI, YOSUKE MIURA, REIKO SAKURAI, SHINSUKE KITAHARA, TAKEHIKO YOKOBORI, KYOICHI KAIRA, AKIRA MOGI, TOSHITAKA MAENO, TAKAYUKI ASAO and TAKESHI HISADA
    Anticancer Research March 2019, 39 (3) 1455-1461; DOI: https://doi.org/10.21873/anticanres.13262
  • You have access
    Identification of Genomic Alterations Acquired During Treatment With EGFR-TKIs in Non-small Cell Lung Cancer
    NAOKI KUBO, TAISHI HARADA, YOSHIMASA SHIRAISHI, KANAME NOSAKI, NORIAKI NAKAGAKI, MASAFUMI TAKESHITA, HIROSHI OUCHI, EIJI IWAMA, KENTARO TANAKA, ISAMU OKAMOTO, HIROYUKI SASAKI and YOICHI NAKANISHI
    Anticancer Research February 2019, 39 (2) 671-677; DOI: https://doi.org/10.21873/anticanres.13162
  • You have access
    Baseline Tumor Size as a Predictive and Prognostic Factor of Immune Checkpoint Inhibitor Therapy for Non-small Cell Lung Cancer
    MASAHIRO KATSURADA, TATSUYA NAGANO, MOTOKO TACHIHARA, TATSUNORI KIRIU, KOICHI FURUKAWA, KIYOKO KOYAMA, TAKEHIRO OTOSHI, REINA SEKIYA, DAISUKE HAZAMA, DAISUKE TAMURA, KYOSUKE NAKATA, NAOKO KATSURADA, MASATSUGU YAMAMOTO, KAZUYUKI KOBAYASHI and YOSHIHIRO NISHIMURA
    Anticancer Research February 2019, 39 (2) 815-825; DOI: https://doi.org/10.21873/anticanres.13180
  • You have access
    Upfront Cranial Radiotherapy Followed by Erlotinib Positively Affects Clinical Outcomes of Epidermal Growth Factor Receptor-mutant Non-small Cell Lung Cancer With Brain Metastases
    KOICHI SARUWATARI, TOKUNORI IKEDA, SHO SAEKI, NAOKI SHINGU, KOSUKE IMAMURA, TAIYOU KOMATU, SUNAO USHIJIMA, HIROTAKA MARUYAMA, KOSUKE KASHIWABARA, YUSUKE TOMITA, HIDENORI ICHIYASU, KAZUHIKO FUJII and TAKURO SAKAGAMI
    Anticancer Research February 2019, 39 (2) 923-931; DOI: https://doi.org/10.21873/anticanres.13195
  • You have access
    Predictors of Acute Radiation Esophagitis in Non-small Cell Lung Cancer Patients Treated With Accelerated Hyperfractionated Chemoradiotherapy
    KENTARO WADA, NORIKO KISHI, NAOYUKI KANAYAMA, TAKERO HIRATA, YOSHIHIRO UEDA, YOSHIFUMI KAWAGUCHI, MASAHIRO MORIMOTO, KOJI KONISHI, FUMIO IMAMURA, KAZUHIKO OGAWA and TERUKI TESHIMA
    Anticancer Research January 2019, 39 (1) 491-497; DOI: https://doi.org/10.21873/anticanres.13139
  • You have access
    Chronic Inflammation as a Potential Predictive Factor of Nivolumab Therapy in Non-small Cell Lung Cancer
    MARTIN SVATON, MILADA ZEMANOVA, JANA SKRICKOVA, LENKA JAKUBIKOVA, VITEZSLAV KOLEK, JURAJ KULTAN, LEONA KOUBKOVA, ALZBETA BEJCKOVA, FRANTISEK SALAJKA, MICHAL HRNCIARIK, BOHUSLAV MELICHAR, DAVID VRANA, MAREK KONECNY, RENATA CHLOUPKOVA and MILOS PESEK
    Anticancer Research December 2018, 38 (12) 6771-6782; DOI: https://doi.org/10.21873/anticanres.13048
  • You have access
    PD-L2 Expression as a Potential Predictive Biomarker for the Response to Anti-PD-1 Drugs in Patients with Non-small Cell Lung Cancer
    SHINKICHI TAKAMORI, KAZUKI TAKADA, GOUJI TOYOKAWA, KOICHI AZUMA, MOTOTSUGU SHIMOKAWA, TOMOKO JOGO, YUICHI YAMADA, FUMIHIKO HIRAI, TETSUZO TAGAWA, AKIHIKO KAWAHARA, JUN AKIBA, ISAMU OKAMOTO, YOICHI NAKANISHI, YOSHINAO ODA, TOMOAKI HOSHINO and YOSHIHIKO MAEHARA
    Anticancer Research October 2018, 38 (10) 5897-5901; DOI: https://doi.org/10.21873/anticanres.12933
  • You have access
    Prominent Nucleoli and Non-glandular Feature Are Independent Predictors of PD-L1 Expression in Lung Adenocarcinoma
    NARA YOON, JIYOUNG KIM, LEE-SO MAENG, JOONG HYUN AHN and EUN SU PARK
    Anticancer Research October 2018, 38 (10) 6003-6008; DOI: https://doi.org/10.21873/anticanres.12949
  • You have access
    Fluoxetine Inhibits DNA Repair and NF-ĸB-modulated Metastatic Potential in Non-small Cell Lung Cancer
    JENG-YUAN WU, SONG-SHEI LIN, FEI-TING HSU and JING-GUNG CHUNG
    Anticancer Research September 2018, 38 (9) 5201-5210; DOI: https://doi.org/10.21873/anticanres.12843

Pages

  • Previous
  • Next
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 23
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire